GSK Announcement May Change Industry Speaker Programs
February 14, 2014, 4:41 PM EST
Law360, New York (February 14, 2014, 4:41 PM EST) -- Two common industry practices, paying health care professionals ("HCPs") to speak on a company’s behalf regarding its products to other HCPs and compensating sales professionals based on prescriptions written by HCPs, are receiving close scrutiny these days in response to an announcement from a big industry player.
GlaxoSmithKline PLC announced in December 2013, that it will stop compensating HCPs for speaking on the company’s behalf regarding its products and related disease areas to other HCPs and attendees who potentially could prescribe or influence the prescribing of...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.